PIK3CA mutation was a commonly reported factor for treatment and prognosis in ESCC patients, but conflicting conclusions were drawn across studies (Wada et al., 2006; Shigaki et al., 2013; Wang et al., 2014). This evidence concerns the gene PIK3CA and esophageal squamous cell carcinoma.